Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
MindMed Announces Voluntary Delisting from Cboe Canada
1 Apr 24
8-K
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
11 Mar 24
8-K
Regulation FD Disclosure
7 Mar 24
8-K
Mindmed Receives Fda Breakthrough Therapy Designation
7 Mar 24
8-K
MindMed Reports 2023 Financial Results and Business Updates
28 Feb 24
8-K
MindMed Announces Business Update and Anticipated Milestones for 2024
8 Jan 24
8-K
MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120
14 Dec 23
8-K
MindMed Reports Third Quarter 2023 Financial Results and Business Highlights
2 Nov 23
8-K/A
Other Events
15 Sep 23
8-K/A
Other Events
15 Sep 23
Registration and prospectus
S-3
Shelf registration
2 Apr 24
D
$75.00 mm in equity, sold $75.00 mm, 2 investors
18 Mar 24
424B5
Prospectus supplement for primary offering
7 Mar 24
S-3MEF
Registration of additional securities for an S-3
7 Mar 24
S-8
Registration of securities for employees
14 Mar 23
424B5
Prospectus supplement for primary offering
29 Sep 22
424B5
Prospectus supplement for primary offering
27 Sep 22
S-3
Shelf registration
3 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Jun 21
S-8
Registration of securities for employees
26 Apr 21
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
DEFA14A
Additional proxy soliciting materials
16 Jun 23
DFAN14A
Additional proxy materials by non-management
16 Jun 23
DFAN14A
Additional proxy materials by non-management
15 Jun 23
DEFA14A
Additional proxy soliciting materials
15 Jun 23
DFAN14A
Additional proxy materials by non-management
12 Jun 23
DEFA14A
Additional proxy soliciting materials
12 Jun 23
DFAN14A
Additional proxy materials by non-management
9 Jun 23
DEFA14A
Additional proxy soliciting materials
9 Jun 23
Other
CORRESP
Correspondence with SEC
28 Apr 23
UPLOAD
Letter from SEC
28 Apr 23
UPLOAD
Letter from SEC
27 Apr 23
EFFECT
Notice of effectiveness
20 May 22
CORRESP
Correspondence with SEC
12 May 22
UPLOAD
Letter from SEC
10 May 22
CERT
Certification of approval for exchange listing
26 Apr 21
EFFECT
Notice of effectiveness
13 Apr 21
Ownership
4
Schond L. Greenway
26 Mar 24
4
Dan Karlin
26 Mar 24
4
Robert Barrow
26 Mar 24
144
Notice of proposed sale of securities
25 Mar 24
144
Notice of proposed sale of securities
25 Mar 24
SC 13G
COMMODORE CAPITAL LP
21 Mar 24
SC 13G
Deep Track Capital, LP
15 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
4
Miri Halperin Wernli
29 Feb 24
4
Schond L. Greenway
29 Feb 24